Related Experiment Video
Updated: Jun 25, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Expanded newborn screening in Oklahoma.
The Journal of the Oklahoma State Medical Association
|March 12, 2009
Summary
Oklahoma is expanding newborn screening using tandem mass spectrometry (MS/MS) to detect more disorders. This advancement builds on the history of newborn screening, addressing current technologies and future possibilities.
Area of Science:
- Biochemistry
- Medical Technology
- Public Health
Background:
- Newborn screening programs aim to detect and treat serious genetic and metabolic disorders early.
- Historically, screening methods have evolved, with tandem mass spectrometry (MS/MS) representing a significant technological leap.
Observation:
- Oklahoma is integrating tandem mass spectrometry (MS/MS) into its existing newborn screening (NBS) program.
- This advanced technology allows for the simultaneous measurement of multiple analytes, greatly increasing the number of detectable disorders.
Findings:
- The implementation of MS/MS in Oklahoma's NBS program will significantly broaden the scope of conditions screened.
- This expansion is expected to improve early diagnosis and intervention for a wider range of congenital disorders.
Implications:
- Expanded NBS capabilities can lead to improved infant health outcomes and reduced long-term disability.
- The adoption of MS/MS technology addresses ongoing discussions and controversies surrounding the scope and ethics of newborn screening.
- Future directions in NBS may involve further technological integration and broader screening panels.
